IK
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prophylaxie et traitement par isavuconazole chez les receveurs de cellules souches hématopoïétiques allogéniques | 2025 | 39 | 145 | ||||
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | 2025 | 7 | 59 | |||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | 2024 | 83 | 195 | |||
| Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers | PLOS ONE | 2021 | 366 | 456 | |||
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection | 2021 | 274 | 441 | |||
| Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2 | PLOS ONE | 2021 | 322 | 164 | |||
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | 2021 | 244 | 243 | |||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | 2021 | 250 | 426 | |||
| Guillain-Barré syndrome as a complication of SARS-CoV-2 infection | Brain, behavior, and immunity | 2020 | 267 | 143 | |||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | 2020 | 464 | 147 | |||
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | 2020 | 348 | 1 | |||
| Quelle place pour les stéroïdes dans le traitement des maladies infectieuses ? | Revue médicale suisse | 2013 | 682 | 543 |
